Viewing
|Articles|March 4, 2009

GSK and UCL team up

GlaxoSmithKline (GSK) and University College London's Institute of Ophthalmology have agreed a deal in which the Institute will investigate the potential of compounds provided by GSK's ophthalmic unit, Ophthiris.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Latest CME